Enalapril Maleate

7 trials 2 recruiting CCardiology

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

2 Recruiting

4 Completed trials

7 Sponsors

16 Countries

Phase II

Phase III/IV

Phase IV

Phase II: 4 Phase III/IV: 1 Phase IV: 2

Oversight events:

9 temporary halts 1 urgent safety measure across 1 trial

View oversight register →

Indications tested

C3 glomerulopathy 1 Overweight 1 Obesity 1 Chronic kidney disease 1

Sponsors using this IMP

Andrea Di Marco 1 Medical University Of Vienna 1 Novartis Pharma AG 1 Novo Nordisk A/S 1 Oslo University Hospital HF 1 Region Skane 1 Uniwersytecki Szpital Kliniczny W Poznaniu 1

All trials

7 total

Prevention of heart disease in heart-healthy patients with diabetes based on a special parameter (NT-proBNP) Pending

2024-519051-28-01 Phase IV 2 countries Medical University Of Vienna
Withdrawal of neurohormonal therapy in patients with non-ischemic cardiomyopathy, no late gadolinium enhancement, and negative genetic testi… Recruiting

2025-521780-12-00 Phase III/IV 1 country Andrea Di Marco
A pilot study of enalapril in venous malformations Recruiting

2023-510076-31-00 Phase II 1 country Oslo University Hospital HF
A research study to see if kidney damage in people with chronic kidney disease and type 2 diabetes living with overweight or obesity can be … Ended

2023-505857-42-00 Phase II 6 countries Novo Nordisk A/S
A proof of concept and dose-finding study of XXB750 in patients with heart failure Ended

2023-504678-39-00 Phase II 11 countries Novartis Pharma AG
Pulmonary REsistance modification under treatment with Sacubitil/valsartaN in paTients with HeartFailure with reduced ejection fraction Ended

2024-517975-19-00 Phase IV 1 country Uniwersytecki Szpital Kliniczny W Poznaniu
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy Ended

2024-515892-36-00 Phase II 1 country Region Skane

Showing 1–7 of 7 trials

← All drugs A–Z